| Role of p38/MAPKs in Alzheimer’s disease: implications for amyloid beta toxicity targeted therapy G Kheiri, M Dolatshahi, F Rahmani, N Rezaei Reviews in the Neurosciences 30 (1), 9-30, 2018 | 155 | 2018 |
| The brain-derived neurotrophic factor: missing link between sleep deprivation, insomnia, and depression M Rahmani, F Rahmani, N Rezaei Neurochemical research 45 (2), 221-231, 2020 | 104 | 2020 |
| Borderless collaboration is needed for COVID-19—A disease that knows no borders K Mohamed, E Rodríguez-Román, F Rahmani, H Zhang, M Ivanovska, ... Infection Control & Hospital Epidemiology 41 (10), 1245-1246, 2020 | 93 | 2020 |
| Plasma levels of brain-derived neurotrophic factor in patients with Parkinson disease: a systematic review and meta-analysis F Rahmani, A Saghazadeh, M Rahmani, AL Teixeira, N Rezaei, ... Brain research 1704, 127-136, 2019 | 91 | 2019 |
| Neurotransmission systems in Parkinson’s disease H Sanjari Moghaddam, A Zare-Shahabadi, F Rahmani, N Rezaei Reviews in the Neurosciences 28 (5), 509-536, 2017 | 84 | 2017 |
| MicroRNA in Alzheimer’s disease revisited: implications for major neuropathological mechanisms R Dehghani, F Rahmani, N Rezaei Reviews in the Neurosciences 29 (2), 161-182, 2018 | 77 | 2018 |
| The effect of insomnia on development of Alzheimer’s disease S Sadeghmousavi, M Eskian, F Rahmani, N Rezaei Journal of neuroinflammation 17 (1), 289, 2020 | 73 | 2020 |
| Medial temporal lobe disconnection and hyperexcitability across Alzheimer’s disease stages L Pasquini, F Rahmani, S Maleki-Balajoo, R La Joie, M Zarei, C Sorg, ... Journal of Alzheimer's disease reports 3 (1), 103-112, 2019 | 61 | 2019 |
| Gene expression and levels of IL-6 and TNFα in PBMCs correlate with severity and functional class in patients with chronic heart failure V Eskandari, AA Amirzargar, MJ Mahmoudi, Z Rahnemoon, F Rahmani, ... Irish Journal of Medical Science (1971-) 187, 359-368, 2018 | 46 | 2018 |
| Brain pathway differences between Parkinson’s disease patients with and without REM sleep behavior disorder M Ansari, F Rahmani, M Dolatshahi, A Pooyan, MH Aarabi Sleep and Breathing 21, 155-161, 2017 | 44 | 2017 |
| Autoimmunity and cytokines in Guillain-Barré syndrome revisited: review of pathomechanisms with an eye on therapeutic options ZE Soltani, F Rahmani, N Rezaei European cytokine network 30, 1-14, 2019 | 43 | 2019 |
| Shedding light on thyroid hormone disorders and Parkinson disease pathology: mechanisms and risk factors S Mohammadi, M Dolatshahi, F Rahmani Journal of Endocrinological Investigation 44, 1-13, 2021 | 37 | 2021 |
| Therapeutic targeting of Toll-like receptors: a review of Toll-like receptors and their signaling pathways in psoriasis F Rahmani, N Rezaei Expert review of clinical immunology 12 (12), 1289-1298, 2016 | 33 | 2016 |
| Association of killer cell immunoglobulin-like receptor genes in iranian patients with rheumatoid arthritis M Nazari, M Mahmoudi, F Rahmani, M Akhlaghi, M Beigy, M Azarian, ... PloS one 10 (12), e0143757, 2015 | 31 | 2015 |
| Exploring white matter microstructure and olfaction dysfunction in early parkinson disease: diffusion MRI reveals new insight S Sobhani, F Rahmani, MH Aarabi, AV Sadr Brain imaging and behavior 13 (1), 210-219, 2019 | 29 | 2019 |
| White matter changes correlates of peripheral neuroinflammation in patients with Parkinson’s disease M Haghshomar, F Rahmani, MH Aarabi, S Shahjouei, S Sobhani, ... Neuroscience 403, 70-78, 2019 | 28 | 2019 |
| Sequential language learning and language immersion in bilingualism: diffusion MRI connectometry reveals microstructural evidence F Rahmani, S Sobhani, MH Aarabi Experimental brain research 235 (10), 2935-2945, 2017 | 27 | 2017 |
| Pathogenesis and promising therapeutics of Alzheimer disease through eIF2α pathway and correspondent kinases R Moradi Majd, M Mayeli, F Rahmani Metabolic Brain Disease 35 (8), 1241-1250, 2020 | 24 | 2020 |
| Plasma neurofilament light chain levels are associated with cortical hypometabolism in Alzheimer disease signature regions M Mayeli, SM Mirshahvalad, V Aghamollaii, A Tafakhori, A Abdolalizadeh, ... Journal of Neuropathology & Experimental Neurology 78 (8), 709-716, 2019 | 24 | 2019 |
| Pathophysiological clues to therapeutic applications of glutamate mGlu5 receptor antagonists in levodopa-induced dyskinesia S Pourmirbabaei, M Dolatshahi, F Rahmani European Journal of Pharmacology 855, 149-159, 2019 | 23 | 2019 |
Nima RezaeiTehran University of Medical Sciences; Universal Scientific Education and Research Network (USERN)Verified email at tums.ac.ir
